FRANKFURT (dpa-AFX) - Schott Pharma shares came under heavy pressure on Wednesday following subdued expectations for the coming financial year. In pre-market trading on the Tradegate trading platform, they fell by 12.6 percent to 32.62 euros compared to the Xetra close. This means that they would fall to their lowest level in Xetra trading since the end of January.

The evening before, the pharmaceutical supplier warned of weak sales of syringes in the coming year.

The predictability of further developments is now very poor, criticized a Borsianer. Barclays analyst Gaurav Jain cut his estimates for organic growth in 2025 from 18 to 10 percent./ajx/jha/